Literature DB >> 19808230

Dystroglycan in the diagnosis of FSGS.

Giovanna Giannico1, Haichun Yang, Eric G Neilson, Agnes B Fogo.   

Abstract

BACKGROUND AND OBJECTIVES: alpha- and beta-dystroglycan (DG), which link the actin cytoskeleton of the podocyte to the glomerular basement membrane, are maintained in FSGS but decreased in minimal change disease (MCD). Fibrosis has been linked to increased fibroblast-specific protein-1 (FSP1) and epithelial-mesenchymal transition. We studied DG, FSP1, and podocyte differentiation in FSGS variants and cases of suspected FSGS. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied renal biopsies with FSGS, not otherwise specified (NOS), tip lesion, or collapsing variants (COLL), versus secondary FSGS or cases without segmental sclerotic lesions where a diagnosis of MCD versus FSGS could not be established (undefined [UNDEF]) and compared the expression of DG, FSP1, and podocyte Wilms' tumor antigen (WT1).
RESULTS: WT1 is markedly decreased in NOS versus normal and correlates with the extent of sclerosis. alpha- and beta-DG are maintained in most primary and secondary FSGS cases. In contrast, alpha-DG is significantly decreased in UNDEF, supporting a diagnosis of MCD. Furthermore, follow-up shows remission or decreased proteinuria in four of six of these UNDEF cases in response to therapy. Interstitial FSP1 is numerically highest in COLL but is only rarely found in tubules or podocytes in any other forms of FSGS.
CONCLUSIONS: We conclude that increased FSP1 may be a marker of the aggressive course of collapsing FSGS. Furthermore, DG staining is a useful adjunct to assist in distinction of FSGS versus MCD in biopsies without defining lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808230      PMCID: PMC2774958          DOI: 10.2215/CJN.01510209

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  28 in total

Review 1.  Mechanisms of disease: Fibroblasts--a new look at an old problem.

Authors:  Eric G Neilson
Journal:  Nat Clin Pract Nephrol       Date:  2006-02

2.  The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  L Barisoni; W Kriz; P Mundel; V D'Agati
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

3.  Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor.

Authors:  S H Gee; F Montanaro; M H Lindenbaum; S Carbonetto
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

4.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

5.  Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue.

Authors:  M Gesemann; A Brancaccio; B Schumacher; M A Ruegg
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

Review 6.  WT1 and glomerular diseases.

Authors:  Patrick Niaudet; Marie-Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-08-23       Impact factor: 3.714

7.  Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.

Authors:  M B Stokes; A M Valeri; G S Markowitz; V D D'Agati
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

8.  Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN.

Authors:  Yoshiharu Nishitani; Masayuki Iwano; Yukinari Yamaguchi; Koji Harada; Kimihiko Nakatani; Yasuhiro Akai; Toshihiko Nishino; Hideo Shiiki; Masao Kanauchi; Yoshihiko Saito; Eric G Neilson
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.

Authors:  D B Thomas; N Franceschini; S L Hogan; S Ten Holder; C E Jennette; R J Falk; J C Jennette
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

10.  Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane.

Authors:  H Yamada; A J Denzer; H Hori; T Tanaka; L V Anderson; S Fujita; H Fukuta-Ohi; T Shimizu; M A Ruegg; K Matsumura
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

View more
  22 in total

1.  Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.

Authors:  Mariana Murea; Jun-Ki Park; Shuchita Sharma; Hideki Kato; Antje Gruenwald; Thiruvur Niranjan; Han Si; David B Thomas; James M Pullman; Michal L Melamed; Katalin Susztak
Journal:  Kidney Int       Date:  2010-06-09       Impact factor: 10.612

Review 2.  Cell-matrix adhesion of podocytes in physiology and disease.

Authors:  Norman Sachs; Arnoud Sonnenberg
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

3.  Dystroglycan does not contribute significantly to kidney development or function, in health or after injury.

Authors:  George Jarad; Jeffrey W Pippin; Stuart J Shankland; Jordan A Kreidberg; Jeffrey H Miner
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

Review 4.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

Review 5.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

Review 6.  Focal Segmental Glomerulosclerosis.

Authors:  Avi Z Rosenberg; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-27       Impact factor: 8.237

Review 7.  Causes and pathogenesis of focal segmental glomerulosclerosis.

Authors:  Agnes B Fogo
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

Review 8.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

9.  Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.

Authors:  Huma Fatima; Marcus J Moeller; Bart Smeets; Hai-Chun Yang; Vivette D D'Agati; Charles E Alpers; Agnes B Fogo
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

10.  Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.

Authors:  Bart Smeets; Fabien Stucker; Jack Wetzels; Isabelle Brocheriou; Pierre Ronco; Hermann-Josef Gröne; Vivette D'Agati; Agnes B Fogo; Toin H van Kuppevelt; Hans-Peter Fischer; Peter Boor; Jürgen Floege; Tammo Ostendorf; Marcus J Moeller
Journal:  Am J Pathol       Date:  2014-10-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.